Amundi EURO STOXX 50 Daily (-1X) Inverse UCITS ETF -Acc-Amundi EURO STOXX 50 Daily (-1X) Inverse UCITS ETF -Acc-Amundi EURO STOXX 50 Daily (-1X) Inverse UCITS ETF -Acc-

Amundi EURO STOXX 50 Daily (-1X) Inverse UCITS ETF -Acc-

No trades

Key stats


Assets under management (AUM)
‪31.64 M‬EUR
Fund flows (1Y)
‪−17.03 M‬EUR
Dividend yield (indicated)
Discount/Premium to NAV
−0.02%
Shares outstanding
‪4.41 M‬
Expense ratio
0.40%

About Amundi EURO STOXX 50 Daily (-1X) Inverse UCITS ETF -Acc-


Issuer
SAS Rue la Boétie
Brand
Amundi
Inception date
Apr 3, 2007
Structure
French SICAV
Index tracked
Euro STOXX 50 Short
Replication method
Synthetic
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
Amundi Asset Management SASU (Investment Management)
Identifiers
2
ISIN FR0010424135
The Lyxor EURO STOXX 50 Daily (-1x) Inverse UCITS ETF - Acc is a UCITS compliant exchange traded fund that aims to track the benchmark index EURO STOXX 50 Short Return Index.

Classification


Asset Class
Equity
Category
Size and style
Focus
Large cap
Niche
Broad-based
Strategy
Vanilla
Geography
Developed Europe
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of February 2, 2026
Exposure type
StocksBonds, Cash & Other
Health Technology
Finance
Electronic Technology
Producer Manufacturing
Technology Services
Stocks95.39%
Health Technology18.48%
Finance18.07%
Electronic Technology15.31%
Producer Manufacturing12.62%
Technology Services10.29%
Energy Minerals7.71%
Utilities4.52%
Non-Energy Minerals2.34%
Commercial Services2.25%
Retail Trade2.24%
Transportation1.03%
Industrial Services0.43%
Consumer Non-Durables0.11%
Bonds, Cash & Other4.61%
Temporary4.61%
Stock breakdown by region
8%90%1%
Europe90.32%
North America8.14%
Middle East1.54%
Latin America0.00%
Asia0.00%
Africa0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


LSK7 invests in stocks. The fund's major sectors are Health Technology, with 18.48% stocks, and Finance, with 18.07% of the basket. The assets are mostly located in the Europe region.
LSK7 top holdings are Bayer AG and SAP SE, occupying 8.78% and 7.96% of the portfolio correspondingly.
LSK7 assets under management is ‪31.64 M‬ EUR. It's risen 2.89% over the last month.
LSK7 fund flows account for ‪−17.03 M‬ EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, LSK7 doesn't pay dividends to its holders.
LSK7 shares are issued by SAS Rue la Boétie under the brand Amundi. The ETF was launched on Apr 3, 2007, and its management style is Passive.
LSK7 expense ratio is 0.40% meaning you'd have to pay 0.40% of your investment to help manage the fund.
LSK7 follows the Euro STOXX 50 Short. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
LSK7 invests in stocks.
LSK7 price has fallen by −0.92% over the last month, and its yearly performance shows a −12.72% decrease. See more dynamics on LSK7 price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −1.07% over the last month, showed a −4.06% decrease in three-month performance and has decreased by −11.99% in a year.
LSK7 trades at a premium (0.02%) meaning the ETF is trading at a higher price than the calculated NAV.